Clinical Trial Update: Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating stereotactic radiation therapy for kidney tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 1 | Status: WITHDRAWN